HPV 16 DNA and mRNA in cervical brush samples quantified by PCR and microwell hybridization

Journal of Virological Methods

Volumn 69, Issue 1-2, 1997, Pages 209-222

  Forslund, Ola ^a   Lindqvist, Pelle ^b   Haadem, Knut ^b   Czeglédy, Judit ^a,c   Göran Hansson, Bengt ^a  

^a Department of Medical Microbiology   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

HPV 16; mRNA; PCR; Quantification

Indexed keywords

MESSENGER RNA; VIRUS DNA;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA HYBRIDIZATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAMPLE; VIRUS CHARACTERIZATION; VIRUS DETECTION; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLORIMETRY; DNA, VIRAL; FEMALE; HUMANS; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0031457855     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(97)00161-4     Document Type: Article

References (34)

1. Bavin P.J., Giles J.A., Deery A., Crow J., Griffiths P.D., Emery V.C., Walker P.G. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br. J. Cancer. 67(3):1993;602-605.
2. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., Schiffman M.H., Moreno V., Kurman R., Shah K.V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87(11):1995;796-802.
3. Bouvard V., Matlashewski G., Gu Z.M., Storey A., Banks L. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology. 203(1):1994;73-80.
4. Cadena D.L., Gill G.N. Receptor tyrosine kineses. FASEB. J 6(6):1992;2332-2337.
5. Chen S.L., Huang C.H., Tsai T.C., Lu K.Y., Tsao Y.P. The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein. Arch. Virol. 141(5):1996;791-800.
6. Crum C.P., Nuovo G., Friedman D., Silverstein S.J. Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers. J. Virol. 62(1):1988;84-90.
7. Cuzick J., Terry G., Ho L., Hollingworth T., Anderson M. Typespecific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br. J. Cancer. 69(1):1994;167-171.
8. de Villiers E.M., Wagner D., Schneider A., Wesch H., Munz F., Miklaw H., zur Hausen H. Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study. Gynecol. Oncol. 44(1):1992;33-39.
9. Durst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. USA. 80(12):1983;3812-3815.
10. Dyson N., Howley P.M., Munger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243(4893):1989;934-937.
11. Gu Z., Matlashewski G. Effect of human papillomavirus type 16 oncogenes on MAP kinase activity. J. Virol. 69(12):1995;8051-8056.
12. Ho L., Terry G., Mansell B., Butler B., Singer A. Detection of DNA and E7 transcripts of human papillomavirus types 16, 18, 31 and 33, TGF beta and GM-CSF transcripts in cervical cancers and precancers. Arch. Virol. 139(1-2):1994;79-85.
13. Huibregtse J.M., Scheffer M. Mechanisms of tumor suppressor protein inactivation by the human papillomavirus E6 and E7 oncoproteins. Semin. Virol. 5:1994;357-367.
14. Kofoed Johnsen C., Stanley M., Norrild B. Analysis of human papillomavirus type 16 E5 oncogene expression in vitro and from bicistronic messenger RNAs. Intervirology. 38:1996;339-345.
15. Leechanachai P., Banks L., Moreau F., Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene. 7(1):1992;19-25.
16. Morrison E.A., Goldberg G.L., Kadish A.S., Burk R.D. Polymerase chain reaction detection of human papillomavirus: quantitation may improve clinical utility. J. Clin. Microbiol. 30(10):1992;2539-2543.
17. Munger K., Phelps W.C., Bubb V., Howley P.M., Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63(10):1989;4417-4421.
18. Saiki R.K., Scharf S., Faloona F., Mullis K.B., Horn G.T., Erlich H.A., Arnheim N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 230(4732):1985;1350-1354.
19. Sambrook, J.E., Fritsch, F., Maniatis, T., 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 314(6006):1985;111-114.
21. Sedman S.A., Barbosa M.S., Vass W.C., Hubbert N.L., Haas J.A., Lowy D.R., Schiller J.T. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J. Virol. 65(9):1991;4860-4866.
22. Sherman L., Alloul N., Golan I., Durst M., Baram A. Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers. Int. J. Cancer. 50(3):1992;356-364.
23. Shirasawa H., Tomita Y., Kubota K., Kasai T., Sekiya S., Takamizawa H., Simizu B. Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J. Virol. 62(3):1988;1022-1027.
24. Smotkin D., Prokoph H., Wettstein F.O. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J. Virol. 63(3):1989;1441-1447.
25. Smotkin D., Wettstein F.O. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA. 83(13):1986;4680-4684.
26. Smotkin D., Wettstein F.O. The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J. Virol. 61(5):1987;1686-1689.
27. Stoler M.H., Rhodes C.R., Whitbeck A., Wolinsky S.M., Chow L.T., Broker T.R. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 23(2):1992;117-128.
28. Straight S.W., Herman B., McCance D.J. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J. Virol. 69(5):1995;3185-3192.
29. Straight S.W., Hinkle P.M., Jewers R.J., McCance D.J. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67(8):1993;4521-4532.
30. Tanimoto H. Occurrence and expression of human papillomavirus type 16 genes in uterine cervical carcinomas. Hiroshima J. Med. Sci. 41(4):1992;71-77.
31. Terry G., Ho L., Jenkins D., Hills M., Singer A., Mansell B., Beverley E. Definition of human papillomavirus type 16 DNA levels in low and high grade cervical lesions by a simple polymerase chain reaction technique. Arch. Virol. 128(1-2):1993;123-133.
32. von Knebel Doeberitz M., Rittmuller C., zur Hausen H., Durst M. Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int. J. Cancer. 51(5):1992;831-834.
33. Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248(4951):1990;76-79.
34. Whitby K., Garson J.A. Optimisation and evaluation of a quantitative chemiluminescent polymerase chain reaction assay for hepatitis C virus RNA. J. Virol. Methods. 51(1):1995;75-88.